Previous Page  11 / 13 Next Page
Information
Show Menu
Previous Page 11 / 13 Next Page
Page Background

Page 38

Notes:

allied

academies

Nov 22-23, 2018 | Paris, France

Joint Event

Nutrition and Health

16

th

International Conference on

26

th

International Conference on

Diabetes and Endocrinology

&

Journal of Insights in Nutrition and Metabolism | Volume 2

Diabetes mellitus in developing country, in the era of high HIV prevalence

Daniel Azmeraw Workluel

ALL African Leprosy, Tuberculosis, Rehabilitation Training Center (ALERT Center) | Ethiopia

D

iabetes mellitus (DM) is a chronic disease with wide

spectrum etiology, risk factors, pathophysiology, and

clinical presentations, as well variety of armamentarium

employed for management of patients with DM nutritional,

non-pharmacological and pharmacological recommendations

applied for mitigating the effect of DM on morbidity and

mortality. I was thought that Type I DMwas the most prevalent

from types of DM, however with advent of urbanization,

decrease physical activities and sedentary life style the trend

of DM is changing in developing countries. Currently from the

place where I came from, Ethiopia the prevalence of DM is

nearly 6 % and there is a rise in prevalence and incidence of

DM attributed to urbanization, decrease physical activities,

sedentary life style, increment in prevalence of obesity

especially in urban areas, as well increase in life expectancy as a

result of decrease inprevalence and incidence of communicable

disease (malaria, relapsing fever..) which translates as aging

of population with increasing the prevalence and risk of non-

communicable disease like DM. Ethiopia is a country with

high prevalence of HIV with estimated prevalence of 1.8%,

with 1.2 million individuals living with HIV and more than

70 % currently on antiretroviral therapy (ART). Besides the

traditional risk factors for DM, 40-70% of patients with HIV are

estimated to have dyslipidemia, and ART incurs additional risk

factor for atherosclerosis, dyslipidemia and DM. On top of this

as ART prolong the life of patients, and the prevalence of DM

especially Type II is logically expected to increase and treatment

of both HIV and DM may complicate the life style of patients

and create difficulty for clinician managing the patients. With

respect am asking the participants of this conference to give

emphasis on DM in developing country especially in area where

HIV is prevalent, by conducting research, providing training on

management of combined chronic illnesses communicable and

non-communicable, support this counties todevelopguidelines.

Speaker Biography

Daniel Azmeraw Workluel has completed MD,

M.PH

and internist at the age of 36 from

Jimma University and University of Gondar, Ethiopia, currently working as leader of internal

medicine case team and senior medical specialist (internist/public health specialist),

clinician at ALERT center, with 3 published research and more than 3 ongoing research

at ALERT center and Armaur Haunssen research institute (AHRI) one of the renowned in

Ethiopia and worldwide.

e:

azmerawdan@gmail.com